2024 Q2 Form 10-Q Financial Statement

#000149315224019782 Filed on May 15, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1 2023 Q1
Revenue $3.393M $3.894M $4.057M
YoY Change 3.49% -4.01% 5.6%
Cost Of Revenue $1.838M $1.940M $2.078M
YoY Change -18.19% -6.66% -16.09%
Gross Profit $1.555M $1.954M $1.979M
YoY Change 50.71% -1.22% 44.97%
Gross Profit Margin 45.82% 50.18% 48.77%
Selling, General & Admin $3.013M $3.218M $4.557M
YoY Change -32.36% -29.39% -31.12%
% of Gross Profit 193.82% 164.66% 230.33%
Research & Development $1.082M $1.130M $1.582M
YoY Change -20.99% -28.57% -27.58%
% of Gross Profit 69.6% 57.83% 79.97%
Depreciation & Amortization $83.99K $102.1K $100.7K
YoY Change -15.36% 1.37% -88.5%
% of Gross Profit 5.4% 5.22% 5.09%
Operating Expenses $4.095M $4.348M $6.140M
YoY Change -30.63% -29.18% -30.6%
Operating Profit -$2.540M -$2.394M -$4.161M
YoY Change -47.85% -42.47% -44.38%
Interest Expense -$349.1K $3.489M -$305.5K
YoY Change 20.55% -1242.01% 1770.79%
% of Operating Profit
Other Income/Expense, Net -$389.2K -$3.922M -$438.4K
YoY Change -7.05% 794.57% 345.97%
Pretax Income -$2.930M -$6.316M -$4.599M
YoY Change -44.62% 37.31% -39.45%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$2.930M -$6.316M -$4.599M
YoY Change -44.62% 37.31% -39.45%
Net Earnings / Revenue -86.36% -162.17% -113.37%
Basic Earnings Per Share -$0.24 -$0.77 -$1.03
Diluted Earnings Per Share -$0.24 -$0.77 -$0.05
COMMON SHARES
Basic Shares Outstanding 11.94M shares 10.89M shares 4.483M shares
Diluted Shares Outstanding 12.39M shares 8.234M shares 4.483M shares

Balance Sheet

Concept 2024 Q2 2024 Q1 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $977.2K $822.9K $2.848M
YoY Change -76.75% -71.1% -69.0%
Cash & Equivalents $977.2K $822.9K $2.848M
Short-Term Investments
Other Short-Term Assets $452.8K $720.7K $838.5K
YoY Change -49.76% -14.05% -41.47%
Inventory $6.382M $6.438M $6.584M
Prepaid Expenses $838.5K
Receivables $1.539M $1.351M $2.911M
Other Receivables $0.00 $0.00 $185.0K
Total Short-Term Assets $9.351M $9.333M $13.37M
YoY Change -32.78% -30.17% -30.45%
LONG-TERM ASSETS
Property, Plant & Equipment $597.4K $666.2K $700.1K
YoY Change -8.23% -4.85% -73.52%
Goodwill $7.403M $7.403M $23.18M
YoY Change -68.06% -68.06%
Intangibles $2.312M $2.457M $10.86M
YoY Change -77.04% -77.37%
Long-Term Investments
YoY Change
Other Assets $251.1K $249.8K $302.9K
YoY Change -29.15% -17.53% 7.81%
Total Long-Term Assets $13.48M $13.89M $38.82M
YoY Change -64.34% -64.23% -52.12%
TOTAL ASSETS
Total Short-Term Assets $9.351M $9.333M $13.37M
Total Long-Term Assets $13.48M $13.89M $38.82M
Total Assets $22.83M $23.22M $52.19M
YoY Change -55.85% -55.5% -47.97%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.145M $2.648M $1.467M
YoY Change 109.33% 80.45% -23.72%
Accrued Expenses $1.664M $1.691M $331.0K
YoY Change -30.2% 410.76% -88.78%
Deferred Revenue $780.0K $349.5K $554.9K
YoY Change 77.2% -37.02%
Short-Term Debt $1.122M $678.6K $933.7K
YoY Change -29.42% -27.32%
Long-Term Debt Due $293.2K $310.0K $451.1K
YoY Change -36.05% -31.28% 1.2%
Total Short-Term Liabilities $12.16M $11.30M $5.233M
YoY Change 90.77% 115.9% -67.53%
LONG-TERM LIABILITIES
Long-Term Debt $321.0K $355.2K $406.4K
YoY Change -23.07% -12.58% -49.38%
Other Long-Term Liabilities $2.274M $2.514M $2.998M
YoY Change -20.0% -16.15% -40.2%
Total Long-Term Liabilities $321.0K $355.2K $406.4K
YoY Change -23.07% -12.58% -93.01%
TOTAL LIABILITIES
Total Short-Term Liabilities $12.16M $11.30M $5.233M
Total Long-Term Liabilities $321.0K $355.2K $406.4K
Total Liabilities $14.76M $14.17M $10.02M
YoY Change 40.11% 41.37% -54.31%
SHAREHOLDERS EQUITY
Retained Earnings -$180.1M -$177.1M -$116.4M
YoY Change 42.52% 52.18%
Common Stock $13.84K $10.89K $90.77K
YoY Change -87.36% -88.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $8.074M $9.053M $42.17M
YoY Change
Total Liabilities & Shareholders Equity $22.83M $23.22M $52.19M
YoY Change -55.85% -55.5% -47.97%

Cashflow Statement

Concept 2024 Q2 2024 Q1 2023 Q1
OPERATING ACTIVITIES
Net Income -$2.930M -$6.316M -$4.599M
YoY Change -44.62% 37.31% -39.45%
Depreciation, Depletion And Amortization $83.99K $102.1K $100.7K
YoY Change -15.36% 1.37% -88.5%
Cash From Operating Activities -$1.430M -$1.553M -$4.235M
YoY Change -43.88% -63.32% -34.96%
INVESTING ACTIVITIES
Capital Expenditures $12.29K $22.40K $5.337K
YoY Change -71.26% 319.67% -107.12%
Acquisitions
YoY Change
Other Investing Activities -$37.60K -$20.68K -$248.9K
YoY Change -70.48% -91.69% -92.74%
Cash From Investing Activities -$49.90K -$43.08K -$254.2K
YoY Change -70.67% -83.05% -92.74%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.647M $1.642M $3.000M
YoY Change -56.38% -45.27% -34.98%
NET CHANGE
Cash From Operating Activities -1.430M -$1.553M -$4.235M
Cash From Investing Activities -49.90K -$43.08K -$254.2K
Cash From Financing Activities 1.647M $1.642M $3.000M
Net Change In Cash 167.1K $3.897K -$1.502M
YoY Change -84.2% -100.26% -72.18%
FREE CASH FLOW
Cash From Operating Activities -$1.430M -$1.553M -$4.235M
Capital Expenditures $12.29K $22.40K $5.337K
Free Cash Flow -$1.443M -$1.575M -$4.240M
YoY Change -44.33% -62.84% -34.12%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 dei Amendment Flag
AmendmentFlag
false
CY2024Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2024Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2024Q1 dei Entity Central Index Key
EntityCentralIndexKey
0000008504
CY2023Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2024Q1 UAVS Amortization Of Unrecognized Periodic Pension Costs1
AmortizationOfUnrecognizedPeriodicPensionCosts1
usd
CY2024Q1 UAVS Stock Issued During Period Value Stock Splits
StockIssuedDuringPeriodValueStockSplits
usd
CY2024Q1 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
usd
CY2024Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
usd
CY2024Q1 UAVS Stock Issued During Period Value Deemed Dividend
StockIssuedDuringPeriodValueDeemedDividend
usd
CY2023Q1 UAVS Stock Issued During Period Value Stock Splits
StockIssuedDuringPeriodValueStockSplits
usd
CY2023Q1 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
usd
CY2023Q1 UAVS Stock Issued During Period Value Deemed Dividend
StockIssuedDuringPeriodValueDeemedDividend
usd
CY2023Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
usd
CY2023Q1 us-gaap Paid In Kind Interest
PaidInKindInterest
usd
CY2023Q1 UAVS Interest Expense For Reduction In Convertible Note Conversion Price
InterestExpenseForReductionInConvertibleNoteConversionPrice
usd
CY2024Q1 UAVS Capitalization Of Platform Development Costs
CapitalizationOfPlatformDevelopmentCosts
usd
CY2023Q1 us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
usd
CY2023Q1 us-gaap Proceeds From Other Short Term Debt
ProceedsFromOtherShortTermDebt
usd
CY2023Q1 us-gaap Payments For Repurchase Of Preferred Stock And Preference Stock
PaymentsForRepurchaseOfPreferredStockAndPreferenceStock
usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
usd
CY2024Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
usd
CY2023Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
usd
CY2024Q1 UAVS Accrued Purchases
AccruedPurchases
usd
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
shares
CY2024Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
CY2024Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
shares
CY2024Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
usd
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
usd
CY2024Q1 us-gaap Share Price
SharePrice
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
pure
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
pure
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
pure
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
pure
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodIntrinsicValue
CY2024Q1 us-gaap Cost Of Revenue
CostOfRevenue
1940025 usd
CY2023Q1 us-gaap Cost Of Revenue
CostOfRevenue
2078437 usd
CY2024Q1 us-gaap Gross Profit
GrossProfit
1954422 usd
CY2023Q1 us-gaap Gross Profit
GrossProfit
1978632 usd
CY2024Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2682658 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3579522 usd
CY2024Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1130229 usd
CY2023Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1582343 usd
CY2024Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
535423 usd
CY2023Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
977875 usd
CY2024Q1 us-gaap Operating Expenses
OperatingExpenses
4348310 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
6139740 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-2393888 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-4161108 usd
CY2024Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-3785344 usd
CY2023Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-305497 usd
CY2024Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-13988 usd
CY2024Q1 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-122367 usd
CY2023Q1 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-132894 usd
CY2024Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-3921699 usd
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-438391 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-6315587 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-4599499 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-6315587 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-4599499 usd
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.77
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.77
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.03
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.03
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8234226 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
8234226 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4482500 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4482500 shares
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-6315587 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-4599499 usd
CY2023Q1 UAVS Amortization Of Unrecognized Periodic Pension Costs1
AmortizationOfUnrecognizedPeriodicPensionCosts1
-43345 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-163653 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
51259 usd
CY2024Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-6479240 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-4504895 usd
CY2024Q1 UAVS Accrued Dividends On Series F Preferred Stock
AccruedDividendsOnSeriesFPreferredStock
-61235 usd
CY2023Q1 UAVS Accrued Dividends On Series F Preferred Stock
AccruedDividendsOnSeriesFPreferredStock
-66921 usd
CY2024Q1 UAVS Deemed Dividends On Series F Preferred Stock
DeemedDividendsOnSeriesFPreferredStock
-5249704 usd
CY2023Q1 UAVS Deemed Dividends On Series F Preferred Stock
DeemedDividendsOnSeriesFPreferredStock
-255976 usd
CY2024Q1 UAVS Total Comprehensive Loss Available To Common Stockholders
TotalComprehensiveLossAvailableToCommonStockholders
-11790179 usd
CY2023Q1 UAVS Total Comprehensive Loss Available To Common Stockholders
TotalComprehensiveLossAvailableToCommonStockholders
-4827792 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
10697556 usd
CY2024Q1 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
950000 usd
CY2024Q1 UAVS Stock Issued During Period Value Conversion Of Convertible Securities One
StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesOne
100000 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings
AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings
-61235 usd
CY2024Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
497701 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
18580 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
3488851 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Stock Issued Ownshare Lending Arrangement Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedOwnshareLendingArrangementIssuanceCosts
-159293 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-163653 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-6315587 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
9052920 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
43224475 usd
CY2023Q1 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
3000000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Stock Dividend
StockIssuedDuringPeriodValueStockDividend
66921 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
512529 usd
CY2023Q1 UAVS Amortization Of Unrecognized Periodic Pension Costs
AmortizationOfUnrecognizedPeriodicPensionCosts
43345 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
51259 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-4599499 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
42165188 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-6315587 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-4599499 usd
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
18580 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
512529 usd
CY2024Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
281448 usd
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1001338 usd
CY2024Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-13988 usd
CY2024Q1 us-gaap Paid In Kind Interest
PaidInKindInterest
344991 usd
CY2024Q1 UAVS Interest Expense For Reduction In Convertible Note Conversion Price
InterestExpenseForReductionInConvertibleNoteConversionPrice
3488851 usd
CY2024Q1 UAVS Defined Benefit Plan Obligation And Other
DefinedBenefitPlanObligationAndOther
-24713 usd
CY2023Q1 UAVS Defined Benefit Plan Obligation And Other
DefinedBenefitPlanObligationAndOther
-148764 usd
CY2024Q1 UAVS Interest Paid On Debt Discount
InterestPaidOnDebtDiscount
164572 usd
CY2023Q1 UAVS Interest Paid On Debt Discount
InterestPaidOnDebtDiscount
168885 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-675975 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
684800 usd
CY2024Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-278062 usd
CY2023Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-138756 usd
CY2024Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
181493 usd
CY2023Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-228733 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-340839 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-383607 usd
CY2024Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
195473 usd
CY2023Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-547170 usd
CY2024Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-337401 usd
CY2023Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
56577 usd
CY2024Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
185000 usd
CY2023Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
67094 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1553093 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4189928 usd
CY2024Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
22398 usd
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
5337 usd
CY2023Q1 UAVS Capitalization Of Platform Development Costs
CapitalizationOfPlatformDevelopmentCosts
139509 usd
CY2024Q1 us-gaap Payments For Software
PaymentsForSoftware
20683 usd
CY2023Q1 us-gaap Payments For Software
PaymentsForSoftware
109345 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-43081 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-254191 usd
CY2024Q1 us-gaap Proceeds From Issuance Of Convertible Preferred Stock
ProceedsFromIssuanceOfConvertiblePreferredStock
950000 usd
CY2023Q1 us-gaap Proceeds From Issuance Of Convertible Preferred Stock
ProceedsFromIssuanceOfConvertiblePreferredStock
3000000 usd
CY2024Q1 UAVS Repayments On Covid Loans
RepaymentsOnCovidLoans
160514 usd
CY2023Q1 UAVS Repayments On Covid Loans
RepaymentsOnCovidLoans
44598 usd
CY2024Q1 us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
497701 usd
CY2024Q1 us-gaap Proceeds From Other Short Term Debt
ProceedsFromOtherShortTermDebt
514000 usd
CY2024Q1 us-gaap Payments For Repurchase Of Preferred Stock And Preference Stock
PaymentsForRepurchaseOfPreferredStockAndPreferenceStock
159293 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1641894 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2955402 usd
CY2024Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-41823 usd
CY2023Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-13212 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
3897 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1501929 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
819024 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
4349837 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
822921 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2847908 usd
CY2024Q1 us-gaap Interest Paid Net
InterestPaidNet
164572 usd
CY2024Q1 UAVS Conversion Of Preferred Stock Series F To Common Stock
ConversionOfPreferredStockSeriesFToCommonStock
2952 usd
CY2023Q1 UAVS Conversion Of Preferred Stock Series F To Common Stock
ConversionOfPreferredStockSeriesFToCommonStock
2305 usd
CY2024Q1 UAVS Dividends On Preferred Stock Series F
DividendsOnPreferredStockSeriesF
61235 usd
CY2023Q1 UAVS Dividends On Preferred Stock Series F
DividendsOnPreferredStockSeriesF
66921 usd
CY2024Q1 UAVS Deemed Dividend On Series F Preferred Stock And Warrant
DeemedDividendOnSeriesFPreferredStockAndWarrant
5249704 usd
CY2023Q1 UAVS Deemed Dividend On Series F Preferred Stock And Warrant
DeemedDividendOnSeriesFPreferredStockAndWarrant
255976 usd
CY2024Q1 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
1-for-20 reverse stock split
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-6315587 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1553093 usd
CY2024Q1 UAVS Working Capital
WorkingCapital
1965996 usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-177148382 usd
CY2024Q1 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_84D_eus-gaap--UseOfEstimates_zsZTCvf0CCyd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86F_zbmcsLIEtFFf">Use of Estimates </span></i>– The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates include the reserve for obsolete inventory, valuation of stock issued for services and stock options, valuation of intangible assets, and valuation of goodwill.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 33.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p>
CY2024Q1 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000 usd
CY2024Q1 us-gaap Cash Uninsured Amount
CashUninsuredAmount
250000 usd
CY2024Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1351355 usd
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2057546 usd
CY2024Q1 us-gaap Allowance For Doubtful Accounts Receivable Noncurrent
AllowanceForDoubtfulAccountsReceivableNoncurrent
123184 usd
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable Noncurrent
AllowanceForDoubtfulAccountsReceivableNoncurrent
158689 usd
CY2024Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
349483 usd
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
226316 usd
CY2024Q1 UAVS Capitalized Software Development Costs For Internaluse Software
CapitalizedSoftwareDevelopmentCostsForInternaluseSoftware
20683 usd
CY2023Q4 UAVS Capitalized Software Development Costs For Internaluse Software
CapitalizedSoftwareDevelopmentCostsForInternaluseSoftware
582148 usd
CY2024Q1 us-gaap Goodwill
Goodwill
7402644 usd
CY2023Q4 us-gaap Goodwill
Goodwill
7402644 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
2456592 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
2615281 usd
CY2024Q1 UAVS Shipping Costs
ShippingCosts
90549 usd
CY2023Q1 UAVS Shipping Costs
ShippingCosts
64936 usd
CY2024Q1 us-gaap Advertising Expense
AdvertisingExpense
1053 usd
CY2023Q1 us-gaap Advertising Expense
AdvertisingExpense
40689 usd
CY2024Q1 UAVS Income Tax Rate Reconciliation Description
IncomeTaxRateReconciliationDescription
The guidance requires the rate reconciliation to include specific categories and provides further guidance on disaggregation of those categories based on a quantitative threshold equal to 5% or more of the amount determined by multiplying pretax income (loss) from continuing operations by the applicable statutory rate. For entities reconciling to the US statutory rate of 21%, this would generally require disclosing any reconciling items that impact the rate by 1.05% or more. ASU 2023-09 is effective for public business entities for annual periods beginning after December 15, 2024 (generally, calendar year 2025) and effective for all other business entities one year later. Entities should adopt this guidance on a prospective basis, though retrospective application is permitted.
CY2024Q1 us-gaap Accounts Receivable Gross
AccountsReceivableGross
1474539 usd
CY2023Q4 us-gaap Accounts Receivable Gross
AccountsReceivableGross
2216235 usd
CY2024Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
123184 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
158689 usd
CY2024Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1351355 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2057546 usd
CY2024Q1 us-gaap Inventory Raw Materials
InventoryRawMaterials
4319010 usd
CY2023Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
4648966 usd
CY2024Q1 us-gaap Inventory Work In Process
InventoryWorkInProcess
838374 usd
CY2023Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
903217 usd
CY2024Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
1653575 usd
CY2023Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
1806239 usd
CY2024Q1 us-gaap Inventory Gross
InventoryGross
6810959 usd
CY2023Q4 us-gaap Inventory Gross
InventoryGross
7358422 usd
CY2024Q1 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
372753 usd
CY2023Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
421442 usd
CY2024Q1 us-gaap Inventory Net
InventoryNet
6438206 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
6936980 usd
CY2024Q1 us-gaap Supplies
Supplies
155482 usd
CY2023Q4 us-gaap Supplies
Supplies
12738 usd
CY2024Q1 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
245442 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
182510 usd
CY2024Q1 us-gaap Prepaid Rent
PrepaidRent
92578 usd
CY2023Q4 us-gaap Prepaid Rent
PrepaidRent
51497 usd
CY2024Q1 us-gaap Prepaid Insurance
PrepaidInsurance
52847 usd
CY2023Q4 us-gaap Prepaid Insurance
PrepaidInsurance
166210 usd
CY2024Q1 us-gaap Prepaid Taxes
PrepaidTaxes
54552 usd
CY2023Q4 us-gaap Prepaid Taxes
PrepaidTaxes
63209 usd
CY2024Q1 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
119744 usd
CY2023Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
72397 usd
CY2024Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
720645 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
548561 usd
CY2024Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1527061 usd
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1792384 usd
CY2024Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
860909 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
992492 usd
CY2022Q2 us-gaap Preferred Stock Value
PreferredStockValue
1000 usd
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
666152 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
799892 usd
CY2024Q1 us-gaap Depreciation
Depreciation
102076 usd
CY2023Q1 us-gaap Depreciation
Depreciation
100697 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
2615281 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Period Increase Decrease
FiniteLivedIntangibleAssetsPeriodIncreaseDecrease
20683 usd
CY2024Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
179372 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
2456592 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Remaining Amortization Period1
FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
P3Y1M13D
CY2024Q1 us-gaap Adjustment For Amortization
AdjustmentForAmortization
179372 usd
CY2023Q1 us-gaap Adjustment For Amortization
AdjustmentForAmortization
900641 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
544433 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
548069 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
380729 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
349923 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
213802 usd
CY2024Q1 UAVS Finite Lived Intangible Assets Amortization Expense After Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour
419636 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
2456592 usd
CY2023Q4 UAVS Accrued Purchases
AccruedPurchases
290126 usd
CY2024Q1 us-gaap Employee Related Liabilities Current And Noncurrent
EmployeeRelatedLiabilitiesCurrentAndNoncurrent
379119 usd
CY2023Q4 us-gaap Employee Related Liabilities Current And Noncurrent
EmployeeRelatedLiabilitiesCurrentAndNoncurrent
278794 usd
CY2024Q1 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
286818 usd
CY2023Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
303217 usd
CY2024Q1 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
573462 usd
CY2023Q4 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
512227 usd
CY2024Q1 us-gaap Accrued Professional Fees Current And Noncurrent
AccruedProfessionalFeesCurrentAndNoncurrent
352459 usd
CY2023Q4 us-gaap Accrued Professional Fees Current And Noncurrent
AccruedProfessionalFeesCurrentAndNoncurrent
211086 usd
CY2024Q1 us-gaap Interest Payable Current
InterestPayableCurrent
82558 usd
CY2023Q4 us-gaap Interest Payable Current
InterestPayableCurrent
326945 usd
CY2024Q1 us-gaap Other Accrued Liabilities Current And Noncurrent
OtherAccruedLiabilitiesCurrentAndNoncurrent
16224 usd
CY2023Q4 us-gaap Other Accrued Liabilities Current And Noncurrent
OtherAccruedLiabilitiesCurrentAndNoncurrent
21957 usd
CY2024Q1 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
1690640 usd
CY2023Q4 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
1944352 usd
CY2024Q1 UAVS Covid Loan Disclosuretext Block
CovidLoanDisclosuretextBlock
<p id="xdx_800_ecustom--CovidLoanDisclosuretextBlock_z7ZluyJigdGh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 4 – <span id="xdx_823_zeAwmqRGHOS4">COVID Loans</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In connection with the senseFly Acquisition, the Company assumed the obligations for two COVID Loans originally made by the SBA to senseFly S.A. on July 27, 2020 (“senseFly COVID Loans”). As of senseFly Acquisition Date, the fair value of the COVID Loan was $<span id="xdx_909_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialLiabilities_iI_c20240331__us-gaap--BusinessAcquisitionAxis__custom--SenseflyMember_zFfpNQ5BzHL7" title="Fair value of the covid loan">1,440,046</span> (“senseFly COVID Loans”). For the three months ended March 31, 2024 and 2023, senseFly S.A. made the required payments on the senseFly COVID Loans, including principal and accrued interest, aggregating $<span id="xdx_901_eus-gaap--RepaymentsOfDebt_c20240101__20240331__us-gaap--DebtInstrumentAxis__custom--SenseflyMember_zdbLJDTAT7d6" title="Payment of principal and interest">160,514</span> and $<span id="xdx_900_eus-gaap--RepaymentsOfDebt_c20230101__20230331__us-gaap--DebtInstrumentAxis__custom--SenseflyMember_z2MUPA9Ma4c4" title="Payment of principal and interest">44,598</span>, respectively. As of March 31, 2024, the Company’s outstanding obligations under the senseFly COVID Loans are $<span id="xdx_90F_eus-gaap--DebtInstrumentCarryingAmount_iI_c20240331__us-gaap--DebtInstrumentAxis__custom--SenseflyCovidLoansMember_zuWK6mPAko8j" title="Outstanding obligations under the covid loans">665,225</span>.On August 25, 2023, the Company modified one (1) of its existing agreements to extend the repayment period of the COVID Loan from a maturity date of December 2023 to June 2025. The other COVID loan remains unchanged.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AGEAGLE AERIAL SYSTEMS INC. AND SUBSIDIARIES <br/> NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS <br/> FOR THE THREE MONTHS ENDED MARCH 31, 2024 AND 2023 <br/> (UNAUDITED)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 4 – COVID Loans-Continued</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p> <p id="xdx_891_eus-gaap--ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_zzLtC0OAhvIj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of March 31, 2024, scheduled principal payments due under the senseFly COVID Loans are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BD_zxWTKluupixl" style="display: none">Schedule of Maturity of SenseFly Covid Loans</span></span></span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font-family: Times New Roman, Times, Serif; font-weight: bold"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td colspan="2" id="xdx_49F_20240331__us-gaap--DebtInstrumentAxis__custom--SenseflyCovidLoansMember_zw4KzhI4WTae" style="font-family: Times New Roman, Times, Serif"> </td><td style="font-family: Times New Roman, Times, Serif"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Year ending December 31,</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_409_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_iI_pp0p0_maLTDz3Lv_zFCNxLHlw9Yc" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; width: 80%"><span style="font-family: Times New Roman, Times, Serif">2024 (rest of year)</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">209,713</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_409_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_iI_pp0p0_maLTDz3Lv_zLYsQsGAxL35" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">2025</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">181,995</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_407_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_iI_pp0p0_maLTDz3Lv_zmjuf9ziDN92" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">2026</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">91,180</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_408_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_iI_pp0p0_maLTDz3Lv_z7agdHsbxuG4" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; text-align: justify; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">2027</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">182,337</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_400_eus-gaap--LongTermDebt_iTI_pp0p0_mtLTDz3Lv_zvzOaaSxW549" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">665,225</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p id="xdx_8AE_zfP3bVOR2aqb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p>
CY2022Q4 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
5000000 shares
CY2022Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.44
CY2022Q4 UAVS Debt Instrument Original Issue Discount Percent
DebtInstrumentOriginalIssueDiscountPercent
0.04 pure
CY2022Q4 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.08 pure
CY2022Q4 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
3285000 usd
CY2022Q4 us-gaap Investment Income Amortization Of Discount
InvestmentIncomeAmortizationOfDiscount
140000 usd
CY2022Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
75000 usd
CY2023Q4 us-gaap Debt Default Longterm Debt Amount
DebtDefaultLongtermDebtAmount
409500 usd
CY2023Q4 us-gaap Long Term Debt
LongTermDebt
4504500 usd
CY2023Q4 UAVS Net Proceeds Percentage
NetProceedsPercentage
0.50 pure
CY2023Q4 us-gaap Proceeds From Debt Net Of Issuance Costs
ProceedsFromDebtNetOfIssuanceCosts
2000000 usd
CY2024Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.60
CY2024Q1 us-gaap Interest Expense
InterestExpense
3488851 usd
CY2024Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
164572 usd
CY2024Q1 us-gaap Shortterm Debt Average Outstanding Amount
ShorttermDebtAverageOutstandingAmount
1026000 usd
CY2024Q1 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
347428 usd
CY2024Q1 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
1512000 usd
CY2024Q1 us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
486000 usd
CY2024Q1 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
347428 usd
CY2024Q1 us-gaap Short Term Borrowings
ShortTermBorrowings
678572 usd
CY2024Q1 us-gaap Dividends
Dividends
61235 usd
CY2022Q2 us-gaap Preferred Stock Value
PreferredStockValue
1000 usd
CY2023Q1 us-gaap Dividends
Dividends
66921 usd
CY2024Q1 UAVS Aggregate Deemed Dividend
AggregateDeemedDividend
5249704 usd
CY2023Q1 UAVS Aggregate Deemed Dividend
AggregateDeemedDividend
255976 usd
CY2024Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
18580 usd
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
512529 usd
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
0 usd
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
125264 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
40.61
CY2023Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
22.04
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P23Y9M18D
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
45880 usd
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
60181 shares
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
41.09
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
22.51
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
65083 shares
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
40.19
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
21.63
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P2Y4M9D
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
58848 shares
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
43.68
CY2024Q1 UAVS Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageFairValue
23.56
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P2Y2M8D
CY2023Q1 us-gaap Share Price
SharePrice
9.00
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P3Y7D
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.6578 pure
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0381 pure
CY2024Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
245050 usd
CY2023Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
261480 usd
CY2024Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3112824 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3525406 usd
CY2024Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
873344 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
901925 usd
CY2024Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2336393 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2721743 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
780132 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
1046064 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
824241 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
738617 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
184653 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
3573707 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
363970 usd
CY2024Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
3209737 usd
CY2024Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
873344 usd
CY2024Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2336393 usd
CY2024Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y8M12D
CY2023Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y10M24D
CY2024Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.061 pure
CY2023Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.061 pure
CY2024Q1 us-gaap Operating Lease Lease Income Lease Payments
OperatingLeaseLeaseIncomeLeasePayments
266401 usd
CY2023Q1 us-gaap Operating Lease Lease Income Lease Payments
OperatingLeaseLeaseIncomeLeasePayments
261222 usd
CY2024Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.60
CY2023Q1 us-gaap Additional Liability Long Duration Insurance Gross Premium Income
AdditionalLiabilityLongDurationInsuranceGrossPremiumIncome
3000000 usd
CY2024Q1 us-gaap Other Commitment
OtherCommitment
2674113 usd
CY2024Q1 us-gaap Goodwill
Goodwill
7402644 usd
CY2024Q1 us-gaap Assets
Assets
23221107 usd
CY2023Q4 us-gaap Goodwill
Goodwill
7402644 usd
CY2023Q4 us-gaap Assets
Assets
25155901 usd
CY2024Q1 us-gaap Revenues
Revenues
3894447 usd
CY2024Q1 us-gaap Cost Of Revenue
CostOfRevenue
1940025 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-2393888 usd
CY2024Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-3921699 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-6315587 usd
CY2023Q1 us-gaap Revenues
Revenues
4057069 usd
CY2023Q1 us-gaap Cost Of Revenue
CostOfRevenue
2078437 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-4161108 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-438391 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-4599499 usd
CY2024Q1 us-gaap Revenues
Revenues
3894447 usd
CY2023Q1 us-gaap Revenues
Revenues
4057069 usd

Files In Submission

Name View Source Status
0001493152-24-019782-index-headers.html Edgar Link pending
0001493152-24-019782-index.html Edgar Link pending
0001493152-24-019782.txt Edgar Link pending
0001493152-24-019782-xbrl.zip Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
form10-q_htm.xml Edgar Link completed
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
uavs-20240331.xsd Edgar Link pending
uavs-20240331_cal.xml Edgar Link unprocessable
uavs-20240331_def.xml Edgar Link unprocessable
uavs-20240331_lab.xml Edgar Link unprocessable
uavs-20240331_pre.xml Edgar Link unprocessable